Risk Markers of Arterial Aging. The Paris Prospective Study III-2
Recruiting
Observational Study
Arterial Stiffness
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Healthy Volunteers Welcome
You do not need to have the condition being studied to take part.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 60 – 95
- Sex
- Any
- Study type
- Observational
- Participants needed
- 7,500 (estimated)
- Sponsor
- Institut National de la Santé Et de la Recherche Médicale, France · Government
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The main objectives of PPS3-2 are (i) to describe the dynamics of vascular aging and baroreflex sensitivity 12 to 16 years a part, (ii) to identify their determinants, and (iii) to quantify the subsequent risk of cardiovascular diseases.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Being enrolled in PPS3 and having signed an informed consent for PPS3-2
Exclusion Criteria:
* Institutionalized participants
* Participants under guardianship
* Participants under judicial safeguard measure
Contacts